Silvercrest Asset Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $378K | Buy |
|
|||||
|
2025
Q1 | $359K | Buy |
|
|||||
|
2024
Q4 | $345K | Buy |
|
|||||
|
2024
Q3 | $330K | Sell |
|
|||||
|
2024
Q2 | $391K | Buy |
|
|||||
|
2024
Q1 | $274K | Buy |
|
|||||
|
2023
Q4 | $259K | Sell |
|
|||||
|
2023
Q3 | $270K | Buy |
|
|||||
|
2023
Q2 | $254K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $231K | Sell |
|
|||||
|
2022
Q3 | $254K | Sell |
|
|||||
|
2022
Q2 | $406K | Sell |
|
|||||
|
2022
Q1 | $381K | Buy |
|
|||||
|
2021
Q4 | $434K | Buy |
|